AIM
CVS icon

Athena Investment Management’s CVS Health CVS Stock Holding History

Athena Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$465K Hold
6,479
– – 0.24% 97
2025
Q4 		$514K Sell
6,479
-10
-0.2% -$788 0.26% 90
2025
Q3 		$489K Hold
6,489
– – 0.25% 92
2025
Q2 		$448K Hold
6,489
– – 0.25% 94
2025
Q1 		$440K Buy
6,489
+296
+5% +$17.7K 0.27% 87
2024
Q4 		$278K Sell
6,193
-428
-6% -$24K 0.16% 120
2024
Q3 		$416K Hold
6,621
– – 0.24% 99
2024
Q2 		$391K Buy
6,621
+78
+1% +$4.88K 0.24% 99
2024
Q1 		$522K Buy
6,543
+156
+2% +$11.9K 0.31% 78
2023
Q4 		$504K Sell
6,387
-156
-2% -$11.1K 0.33% 73
2023
Q3 		$457K Hold
6,543
– – 0.33% 70
2023
Q2 		$452K Hold
6,543
– – 0.31% 73
2023
Q1 		$486K Sell
6,543
-10
-0.2% -$839 0.35% 68
2022
Q4 		$611K Buy
6,553
+112
+2% +$10.8K 0.45% 53
2022
Q3 		$614K Sell
6,441
-132
-2% -$13.1K 0.52% 47
2022
Q2 		$609K Sell
6,573
-17
-0.3% -$1.66K 0.48% 48
2022
Q1 		$670K Buy
+6,590
New +$692K 0.52% 47

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Athena Investment Management's CVS Position: Q1 2026 in Review

Athena Investment Management held its CVS Health (CVS) position steady in Q1 2026 at 6,479 shares worth $465K. The position accounts for 0.24% of the portfolio, ranked #97.

Athena Investment Management first reported a position in CVS in Q1 2022 and has held it in 17 quarters since. The position peaked at $670K in Q1 2022. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Athena Investment Management held 6,479 shares of CVS Health worth $465K as of Q1 2026.
  • Athena Investment Management left its CVS Health share count unchanged in Q1 2026.
  • CVS Health made up 0.24% of Athena Investment Management's portfolio in Q1 2026, its #97 holding.
  • Athena Investment Management first reported a position in CVS Health in Q1 2022 and has held it in 17 quarters since.
  • Athena Investment Management's CVS Health position peaked at $670K in Q1 2022.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Athena Investment Management's 13F filing for Q1 2026, filed 12 May 2026.